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1 |  BACKGROUND
Food allergy is an immunologically mediated hypersensi-
tivity reaction. Food allergies are examined with skin prick 
tests and laboratory tests. In food allergy, many allergens are 
not available as standardized allergen extracts, or the extracts 
does not contain the relevant allergen. Also, the predictive 
value of skin prick testing demonstrating a true allergic reac-
tion over isolated sensitization is higher than the predictive 
value of specific IgE with components.1,2 Therefore, prick-
by-prick testing with native food is a commonly used proce-
dure to aid better diagnostic results. This, however, increases 
the chance of systemic reactions. Also, due to the increasing 
demands for standardization in the medical industry and the 
following decreasing availability of allergen extracts, has cre-
ated a paradox need for more unstandardized prick-by-prick 
testing. We here present a case of anaphylaxis following 
prick- by-prick testing to peanuts and aid to raise awareness 
toward the possible occurrence of systemic reactions when 
performing skin prick testing.
2 |  CASE REPORT
A 39-year-old man came to our clinic for examination of 
food allergies. He had experienced repeated anaphylaxis, 
presenting with asthma and urticaria, due to ingestion of pea-
nut, cashew nut, hazelnut, banana, and fish. He underwent 
skin prick testing to aeroallergens with standardized extracts 
several years ago with no special occurrences. He had un-
dergone successful subcutaneous allergen immunotherapy to 
birch and timothy 10 years ago. As a child, he had suffered 
from atopic dermatitis until the age of three. The patient had 
gastroesophageal reflux treated with 20  mg pantoprazole 
daily, no other regular medication or comorbidities.
At our clinic, the patient underwent prick testing with 
standardized prick test extracts (ALK) for cat, dog, house 
dust mite, birch, timothy, egg white, cow milk, wheat, and 
peanut. We simultaneously performed prick-by-prick testing 
with roasted and salted peanut, banana, and chili-coated pea-
nuts, which the patient brought for testing.
After 10 minutes, the patient developed severe local swell-
ing of the area where peanut prick tests had been performed. 
The swelling increased to an urticarial weal of 10 cm diame-
ter, and the redness quickly spread along the lymphovascular 
drainage path to the axilla (Figure 1). Only after reaching the 
axilla, systematic symptoms occurred. After 15  minutes, he 
developed urticaria in the axilla that spread to the thorax and 
both arms. He also developed a dry cough, shortness of breath, 
and wheezing. Measurement of peak expiratory flow (PEF) 
fell to 300 L/min, and he had obstructive pulmonary sounds 
on auscultation. Blood pressure: 146/93 mmHg. Pulse rate: 88 
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Anaphylaxis due to prick-by-prick testing is a rare but potentially life-threatening 
complication. Personnel performing testing should be able to recognize and treat 
anaphylaxis. Adrenaline must be available. In high-risk patients with a history of 
anaphylaxis, specific igE with components and a basophile activation test is desirable 
before skin prick testing.
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beats per minute. He had a saturation of 100% O2 throughout. 
The patient was treated with 0.5 mg adrenaline (1 mg/mL) in-
tramuscular and five puffs a 0.2 mg of salbutamol via inhala-
tion chamber. He quickly responded with subjective improved 
breathing and regress of the urticaria. He received 5 mg de-
sloratadine orally and 20 mg of stand by prednisolone tablets. 
After an observation time of 2 hours, he was resituated with 
a blood pressure of 133/84 mm Hg, pulse rate 59, saturation 
100% O2, and a peak expiratory flow of 510 L/min. Pulmonary 
auscultation normalized and the skin showed only a residual 
local swelling around the prick tests. Blood tests obtained later 
the same day showed total IgE 272  kU/L (<120), tryptase 
6.1 mcg/L (<12), specific Ig E for peanut 89 KU/L (<0.35), 
Ara h8 < 0.35 kU/L (<0.35), Ara h1 23.4 kU/L (<0.35) and 
Ara h2 58.1 kU/L (<0.35), Ara h9 was < 0.35 kU/L. There was 
no positive IgE for fish, shellfish, and tropomyosin. Specific 
IgE for banana was <0.35 kU/L. The patient shoved a blood 
profile with broad sensitization toward all treenuts and al-
monds including components for storage proteins, but the LTP 
components Ara h9, Cor a 8, Jug r 3 where negative. The pa-
tient is now at good health and has follow-up appointments for 
further allergy evaluation at our clinic. The patient has been 
supplied with an adrenaline autoinjector and is instructed to 
avoid nut and peanut consumption.
3 |  DISCUSSION
Anaphylaxis due to prick and prick-by-prick testing is known 
but rare. The prevalence is estimated between 0,02% and 
0,12%.3,4 Very rarely fatalities due to skin prick tests are re-
ported. A survey by Bernstein et al5 found one fatality due to 
skin prick tests over 12 years in North America. We detected 
the following risk factors for anaphylaxis in our patient: large 
local reaction to skin prick testing, previous anaphylaxis due 
to peanut, peanut specific IgE peanut 89 kU/L (<0, 35 kU/L), 
and a component sensitization pattern of storage proteins 
(Ara h1 and Ara h2). In peanut allergy, the molecular profile 
of allergy components has been seen to predict real peanut 
allergy in some study populations.6 A combined sensitization 
pattern of Ara h1, Ara h 2, and Ara h 3 is linked with a risk of 
more severe reactions,7 but studies have shown several limi-
tations and inconsistencies, and this has been pointed out in 
an AAAAI/ACAAI/JCAAI food allergy position paper.8 In 
retrospect, the high numbers of prick tests performed on our 
patient, including three simultaneous tests of peanut (includ-
ing two prick-by-prick), may well have increased the risk of 
anaphylaxis and the number of simultaneous test will be re-
duced in the future. Also if the peanut IgE with components 
had been obtained bevor skin prick testing, the number of 
peanut allergens tested most likely would have been reduced, 
possibly avoiding the patient's anaphylaxis.
It is however important to remember that specific IgE 
components can only demonstrate sensitization and must be 
combined with further testing and the patient's history to 
demonstrate clinical allergy. This challenge of interpreting 
laboratory results in allergy is well demonstrated in our pa-
tient as he had also experienced anaphylaxis after ingestion 
of banana and several fish species (in absence of nut ex-
posure), and he has no positive specific IgE toward these 
allergens. If a skin prick test is impracticable, a combination 
of molecular diagnostic and basophile activation test should 
be obtained, and if negative, an oral provocation test can be 
considered.
Ara h 2 is considered the main component for diagnosing 
real peanut allergy, especially when the level of Ara h 2 is 
high compared to the level of total IgE. In Norway, many 
patients have mild peanut reactions despite high total IgE to 
peanut due to monosensitization to Ara h 8 ( a PR-10 pro-
tein). This is a result of high birch exposure with sensitization 
to the cross reacting protein Bet v 1. LTP (panallergen) sen-
sitization is rare in Norway, but is a known challenge in the 
Mediterranean region and a risk factor for severe reactions.
The use of molecular cutoffs differs between study popu-
lations in age and geographic regions, and this must be con-
sidered when using molecular diagnosis in regular practice. 
Also, this is still a costly test and only few Norwegian hospi-
tals perform molecular allergy testing. As skin prick testing 
is per now seen as superior in predicting clinical allergy, this 
F I G U R E  1  The picture shows the local spreading of the allergic 
reaction on the left arm where the prick-by-prick test was performed. 
The severe local spread anticipated the systemic reaction
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is normally the first procedure performed. However in pa-
tients with anaphylaxis after food ingestion, measuring base 
line tryptase, specific IgE and components of the suspected 
culprit is desirable bevor skin prick testing. Per now, we do 
not use molecular diagnosis as a single decisive tool, but as 
one instrument out of several to evaluate the severity of an al-
lergy, to predict potential for cross reactions and for advising 
patients on managing their reactions.
In retrospect, the high numbers of prick tests performed 
including three simultaneous tests of peanut (including two 
prick-by-prick) may well have increased the risk of ana-
phylaxis. As the number of available commercial allergen 
extracts has fallen decreased due to higher demands of stan-
dardization and the following economic considerations,9 
prick-by-prick testing is becoming more utilized. Hence, the 
number of prick test reactions could be rising, and knowl-
edge of the potential for systemic allergic reactions anaphy-
laxis and its treatment is essential. Anaphylaxis is a severe, 
possible life-threatening hypersensitivity reaction. Our pa-
tient received anaphylaxis treatment in line with interna-
tional guidelines10 with prompt intramuscular administration 
of 0,5 mL (1 mg/mL) adrenaline. Adrenaline is the drug of 
choice in anaphylaxis treatment, and antihistamines, steroids, 
salbutamol, and other medications are additive treatments 
to be considered after adrenaline administration. A repeated 
challenge in the treatment of anaphylaxis is the late recogni-
tion of anaphylaxis and the low adherence to the guidelines 
concerning adrenaline administration, and the importance of 
having adrenaline available while testing cannot be stressed 
enough.11
4 |  LEARNING POINTS
• Even though anaphylaxis due to skin prick test includ-
ing prick-by-prick testing is rare, it can occur at any time 
during testing.
• This case is an important reminder of the risk of anaphy-
laxis due to skin prick testing, and the need to be pre-
pared to treat anaphylaxis everywhere skin prick tests are 
performed.
• In patients with a story of anaphylaxis to a suspected cul-
prit, obtaining baseline tryptase, specific IgE with compo-
nents, is desirable bevor considering skin prick testing.
• Molecular diagnostics can aid decision-making bevor skin 
prick testing the patient.
• Anaphylaxis is treated with administration of intramuscu-
lar adrenaline.
• We suggest increased awareness toward patients with large 




Marie Alnæs: is the single author on the case report. All work 
involved on the report was performed by Marie Alnæs.
CONSENT STATEMENT
The patient has given his written consent to publication of 
the case.
ORCID
Marie Alnæs   https://orcid.org/0000-0001-9703-4917 
REFERENCES
 1. Heinzerling L, Mari A, Bergmann K-C, et al. The skin prick test – 
European standards. Clin Transl Allergy. 2013;2013(3):3.
 2. Larenas-Linnemann D, Luna-Pech JA, Mösges R. Debates in al-
lergy medicine: allergy skin testing cannot be replaced by molecu-
lar diagnosis in the near future. World Allergy Organ J. 2017;10:32.
 3. Liccardi G, D’Amato G, Walter Canonica G, et al. Systemic re-
actions from skin testing: literature review. J Invest Allergol Clin 
Immunol. 2006;16(2):75-78.
 4. Norrman G, Falth-Magnusson K. Adverse reactions to skin prick 
testing in children: prevalence and possible risk factors. Pediatr. 
Allergy Immunol. 2009;20:273-278.
 5. Bernstein DI, Wanner Mark, Borish L, et al. Twelve-year survey of 
fatal reactions to allergen injections and skin testing: 1990–2001. J 
Allergy Clin Immunol. 2004;113(6):1129-1136.
 6. Lieberman P, Glaumann S, Batelson S, et al. The utility of peanut 
components in the diagnosis of IgE-mediated peanut allergy among 
distinct populations. J Allergy Clin Immunol Pract. 2013;1:75-82.
 7. van Erp FC, van Erp FC, Klemans RJB, Meijer Y, van der Ent 
CK, Knulst AC. Using component-resolved diagnostics in the man-
agement of peanut-allergic patients. Curr Treat Options Allergy. 
2016;2016(3):169-180.
 8. Sampson HA, Aceves S, Bock SA, et al. Food allergy: 
a practice parameter update. J Allergy Clin Immunol. 
2014;134(2014):1016-1025.
 9. Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test - 
European standards. Clin Transl Allergy. 2013;3(1):3.
 10. Simons FER, Ardusso LRF, Bilò MB, Cardona V, et al. 
International consensus on (ICON) anaphylaxis. World Allergy 
Organ J. 2014;7(1):9.
 11. Ribeiro M, Herberto JC. Diagnosis and treatment of anaphylaxis: 
there is an urgent needs to implement the use of guidelines, Einstein 
(Sao Paulo). 2017;15(4):500-506.
How to cite this article: Alnæs M. Anaphylaxis 
following prick-by-prick testing with peanut. Clin 
Case Rep. 2020;00:1–3. https://doi.org/10.1002/
ccr3.3154
